| |
| |
|
| Insider
Information: |
Cavalier David |
| Relationship: |
Director |
| City: |
Research Triangle Pk |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,000 |
|
|
Indirect Shares
|
39,748,589 |
|
|
| Direct
Value |
$6,460 |
|
|
|
Indirect Value
|
$40 |
|
|
| Total
Shares |
39,750,589 |
|
|
| Total
Value |
$6,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
Director, 10% Owner |
|
0 |
2011-02-16 |
39,748,589 |
Premium* |
|
|
Anixa Biosciences Inc |
ANIX |
Director |
2019-04-29 |
2,000 |
2019-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIX |
Anixa Biosciences Inc |
Director |
– • – |
2019-04-29 |
4 |
B |
$4.21 |
$8,420 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2011-02-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(882,488) |
39,748,589 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2010-12-28 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,500,000 |
40,631,077 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2010-08-11 |
4 |
B |
$0.00 |
$0 |
I/I |
2,500,000 |
34,415,876 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2010-07-30 |
4 |
A |
$0.28 |
$1,650,000 |
I/I |
5,892,857 |
31,915,876 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-28 |
4/A |
B |
$0.48 |
$4,750 |
I/I |
10,000 |
26,023,019 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-24 |
4/A |
A |
$0.00 |
$0 |
I/I |
714,286 |
26,013,019 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-24 |
4 |
A |
$0.00 |
$0 |
I/I |
714,286 |
25,953,019 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-23 |
4/A |
B |
$0.43 |
$4,300 |
I/I |
10,000 |
25,298,733 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-22 |
4/A |
B |
$0.42 |
$4,150 |
I/I |
10,000 |
25,288,733 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-21 |
4/A |
B |
$0.43 |
$4,338 |
I/I |
10,000 |
25,278,733 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-18 |
4/A |
B |
$0.38 |
$3,825 |
I/I |
10,000 |
25,268,733 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-12-17 |
4/A |
B |
$0.35 |
$7,076 |
I/I |
20,000 |
25,258,733 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-10-06 |
4 |
A |
$0.35 |
$12,848 |
I/I |
36,993 |
25,238,733 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-10-06 |
4 |
OE |
$0.35 |
$1,000,000 |
I/I |
2,857,143 |
25,201,740 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-10-06 |
4 |
B |
$0.28 |
$1,650,000 |
I/I |
5,892,857 |
22,344,597 |
2.25 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-07-31 |
4 |
A |
$0.36 |
$34,709 |
I/I |
95,537 |
16,451,740 |
0 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-04-22 |
4 |
B |
$0.39 |
$7,800 |
I/I |
20,000 |
16,356,203 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-04-02 |
4 |
B |
$0.39 |
$7,850 |
I/I |
20,000 |
16,336,203 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-03-30 |
4/A |
B |
$0.28 |
$1,500,000 |
I/I |
5,357,143 |
16,316,203 |
2.25 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-03-30 |
4 |
B |
$0.28 |
$1,500,000 |
I/I |
5,357,143 |
16,186,203 |
2.25 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-02-24 |
4/A |
B |
$0.42 |
$8,350 |
I/I |
20,000 |
10,959,060 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-02-11 |
4/A |
B |
$0.45 |
$9,000 |
I/I |
20,000 |
10,939,060 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-02-10 |
4/A |
B |
$0.43 |
$17,352 |
I/I |
40,000 |
10,919,060 |
2.17 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Director |
– • • |
2009-01-31 |
4 |
B |
$0.35 |
$27,784 |
I/I |
79,838 |
10,829,060 |
2.25 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
